ArticleWorld journal of urology2019

Combination of multiparametric magnetic resonance imaging and transrectal ultrasound-guided prostate biopsies is not enough for identifying patients eligible for hemiablative focal therapy for prostate cancer.

Young Hyo Choi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.